HUE050744T2 - Ciklusos amin származék és gyógyszerészeti alkalmazása - Google Patents
Ciklusos amin származék és gyógyszerészeti alkalmazásaInfo
- Publication number
- HUE050744T2 HUE050744T2 HUE17744386A HUE17744386A HUE050744T2 HU E050744 T2 HUE050744 T2 HU E050744T2 HU E17744386 A HUE17744386 A HU E17744386A HU E17744386 A HUE17744386 A HU E17744386A HU E050744 T2 HUE050744 T2 HU E050744T2
- Authority
- HU
- Hungary
- Prior art keywords
- amine derivative
- pharmaceutical use
- cyclic amine
- cyclic
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Toys (AREA)
- Portable Nailing Machines And Staplers (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016015512 | 2016-01-29 | ||
| JP2016212629 | 2016-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE050744T2 true HUE050744T2 (hu) | 2021-01-28 |
Family
ID=59398579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17744386A HUE050744T2 (hu) | 2016-01-29 | 2017-01-27 | Ciklusos amin származék és gyógyszerészeti alkalmazása |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10364222B2 (hu) |
| EP (1) | EP3409660B1 (hu) |
| JP (1) | JP6807054B2 (hu) |
| KR (1) | KR20180100573A (hu) |
| CN (1) | CN108473426B (hu) |
| AU (1) | AU2017210685B2 (hu) |
| BR (1) | BR112018015125A2 (hu) |
| CA (1) | CA3009971C (hu) |
| DK (1) | DK3409660T3 (hu) |
| ES (1) | ES2822606T3 (hu) |
| HU (1) | HUE050744T2 (hu) |
| IL (1) | IL260230B (hu) |
| MX (1) | MX2018008454A (hu) |
| MY (1) | MY195416A (hu) |
| PH (1) | PH12018501434A1 (hu) |
| PL (1) | PL3409660T3 (hu) |
| PT (1) | PT3409660T (hu) |
| RU (1) | RU2696862C1 (hu) |
| SG (1) | SG11201805474PA (hu) |
| TR (1) | TR201912580U5 (hu) |
| TW (1) | TWI691486B (hu) |
| WO (1) | WO2017131156A1 (hu) |
| ZA (1) | ZA201804325B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2019022234A1 (ja) * | 2017-07-27 | 2020-05-28 | 東レ株式会社 | 炎症性腸疾患の治療剤又は予防剤 |
| CA3071235A1 (en) * | 2017-07-27 | 2019-01-31 | Toray Industries, Inc. | Therapeutic agent or preventive agent for alopecia areata |
| TW201910312A (zh) * | 2017-07-28 | 2019-03-16 | 日商東麗股份有限公司 | 環狀胺衍生物及其醫藥用途 |
| WO2019044940A1 (ja) * | 2017-08-31 | 2019-03-07 | 東レ株式会社 | 環状アミン誘導体及びその医薬用途 |
| BR112020013438A2 (pt) | 2018-01-31 | 2020-12-01 | Toray Industries, Inc. | derivado de amina cíclico, medicamento, antagonista de receptor órfão gama relacionado a retinoide, e, agentes terapêuticos ou agentes preventivos para uma doença autoimune, para psoríase ou alopecia areata, para uma doença alérgica, para dermatite alérgica e para dermatite de contato ou dermatite atópica |
| US11230555B2 (en) | 2018-03-12 | 2022-01-25 | Escalier Biosciences B.V. | Bicyclic RORγ modulators |
| CN112118841A (zh) | 2018-03-12 | 2020-12-22 | 爱思凯利尔生物科学私人有限责任公司 | 螺环ROR-γ调节剂 |
| CN111548303A (zh) * | 2020-06-28 | 2020-08-18 | 山东美泰医药有限公司 | 一种盐酸左布比卡因的杂质及其制备和分析方法 |
| CN113252831B (zh) * | 2021-05-20 | 2022-08-26 | 京博农化科技有限公司 | N-氯甲酰基-n-[4-（三氟甲氧基）苯基]氨基甲酸甲酯超高效液相色谱分析方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101203512A (zh) | 2005-04-22 | 2008-06-18 | 第一三共株式会社 | 杂环化合物 |
| GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| EA201000958A1 (ru) * | 2007-12-12 | 2010-12-30 | Астразенека Аб | Пептидилнитрилы и их применение в качестве ингибиторов дипептидилпептидазы i |
| US8703761B2 (en) | 2008-07-15 | 2014-04-22 | Novartis Ag | Organic compounds |
| JP5705748B2 (ja) * | 2009-02-18 | 2015-04-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体を変調する複素環化合物 |
| WO2012027965A1 (en) | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
| WO2012064744A2 (en) | 2010-11-08 | 2012-05-18 | Lycera Corporation | Tetrahydroquinoline and related bicyclic compounds for inhibition of rorϒ activity and the treatment of disease |
| MX2013012542A (es) | 2011-04-28 | 2013-11-20 | Japan Tobacco Inc | Compuestos de amida y aplicacion farmaceutica para el mismo. |
| WO2012158784A2 (en) | 2011-05-16 | 2012-11-22 | Theodore Mark Kamenecka | Modulators of the nuclear hormone receptor ror |
| US9156837B2 (en) | 2011-07-29 | 2015-10-13 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| GB201207406D0 (en) * | 2012-04-27 | 2012-06-13 | Glaxo Group Ltd | Novel compounds |
| EA201791271A1 (ru) * | 2012-05-31 | 2018-01-31 | Фенекс Фармасьютикалз Аг | ТИАЗОЛЫ, ЗАМЕЩЕННЫЕ КАРБОКСАМИДОМ ИЛИ СУЛЬФОНАМИДОМ, И РОДСТВЕННЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ ДЛЯ ОРФАННОГО ЯДЕРНОГО РЕЦЕПТОРА RORγ |
| BR112015022226A2 (pt) * | 2013-03-14 | 2017-07-18 | Celtaxsys Inc | inibidores de leucotrieno a4 hidrolase |
| WO2015103508A1 (en) * | 2014-01-06 | 2015-07-09 | Bristol-Myers Squibb Company | CARBOCYCLIC SULFONE RORγ MODULATORS |
| ES2704460T3 (es) * | 2014-01-06 | 2019-03-18 | Bristol Myers Squibb Co | Moduladores de ROR gamma de ciclohexilsulfona |
| WO2015129853A1 (ja) * | 2014-02-27 | 2015-09-03 | 東レ株式会社 | 環状アミン誘導体及びその医薬用途 |
-
2017
- 2017-01-25 TW TW106102788A patent/TWI691486B/zh active
- 2017-01-27 CN CN201780008139.2A patent/CN108473426B/zh active Active
- 2017-01-27 MY MYPI2018000987A patent/MY195416A/en unknown
- 2017-01-27 ES ES17744386T patent/ES2822606T3/es active Active
- 2017-01-27 CA CA3009971A patent/CA3009971C/en active Active
- 2017-01-27 WO PCT/JP2017/002924 patent/WO2017131156A1/ja active Application Filing
- 2017-01-27 DK DK17744386.8T patent/DK3409660T3/da active
- 2017-01-27 MX MX2018008454A patent/MX2018008454A/es unknown
- 2017-01-27 AU AU2017210685A patent/AU2017210685B2/en active Active
- 2017-01-27 PT PT177443868T patent/PT3409660T/pt unknown
- 2017-01-27 US US16/072,482 patent/US10364222B2/en active Active
- 2017-01-27 HU HUE17744386A patent/HUE050744T2/hu unknown
- 2017-01-27 EP EP17744386.8A patent/EP3409660B1/en active Active
- 2017-01-27 RU RU2018126968A patent/RU2696862C1/ru active
- 2017-01-27 JP JP2017507454A patent/JP6807054B2/ja active Active
- 2017-01-27 SG SG11201805474PA patent/SG11201805474PA/en unknown
- 2017-01-27 PL PL17744386T patent/PL3409660T3/pl unknown
- 2017-01-27 KR KR1020187019685A patent/KR20180100573A/ko not_active Application Discontinuation
- 2017-01-27 BR BR112018015125-4A patent/BR112018015125A2/pt active Search and Examination
-
2018
- 2018-06-24 IL IL260230A patent/IL260230B/en active IP Right Grant
- 2018-06-27 ZA ZA2018/04325A patent/ZA201804325B/en unknown
- 2018-07-04 PH PH12018501434A patent/PH12018501434A1/en unknown
-
2019
- 2019-08-21 TR TR2019/12580U patent/TR201912580U5/tr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2017131156A1 (ja) | 2018-11-22 |
| PT3409660T (pt) | 2020-07-31 |
| EP3409660B1 (en) | 2020-07-01 |
| US10364222B2 (en) | 2019-07-30 |
| PH12018501434A1 (en) | 2019-03-04 |
| EP3409660A4 (en) | 2019-06-26 |
| CN108473426B (zh) | 2021-09-07 |
| PL3409660T3 (pl) | 2021-01-25 |
| CA3009971A1 (en) | 2017-08-03 |
| MX2018008454A (es) | 2018-08-14 |
| IL260230B (en) | 2020-06-30 |
| SG11201805474PA (en) | 2018-07-30 |
| JP6807054B2 (ja) | 2021-01-06 |
| KR20180100573A (ko) | 2018-09-11 |
| MY195416A (en) | 2023-01-20 |
| TW201731816A (zh) | 2017-09-16 |
| CN108473426A (zh) | 2018-08-31 |
| ZA201804325B (en) | 2019-09-25 |
| US20180370916A1 (en) | 2018-12-27 |
| WO2017131156A1 (ja) | 2017-08-03 |
| RU2696862C1 (ru) | 2019-08-07 |
| AU2017210685A1 (en) | 2018-07-05 |
| ES2822606T3 (es) | 2021-05-04 |
| TR201912580U5 (tr) | 2020-09-21 |
| DK3409660T3 (da) | 2020-08-31 |
| BR112018015125A2 (pt) | 2019-02-26 |
| CA3009971C (en) | 2024-03-19 |
| AU2017210685B2 (en) | 2020-09-24 |
| TWI691486B (zh) | 2020-04-21 |
| EP3409660A1 (en) | 2018-12-05 |
| IL260230A (en) | 2018-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201705293B (en) | Cyclic amine derivative and pharmaceutical use thereof | |
| HK1232224A1 (zh) | 取代脲衍生物及其在藥物中的應用 | |
| HK1259145A1 (zh) | 3-脫氧衍生物及其藥物組合物 | |
| HUE050744T2 (hu) | Ciklusos amin származék és gyógyszerészeti alkalmazása | |
| HK1252026A1 (zh) | 藥物組合及其應用 | |
| IL272385A (en) | Drug compound and methods of preparation | |
| PT3050877T (pt) | Derivado de amina cíclica e sua utilização farmacêutica | |
| HK1232211A1 (zh) | 二甲基吡啶胺衍生物及其醫藥用途 | |
| ZA201901263B (en) | Crystals of cyclic amine derivative and pharmaceutical use thereof | |
| EP3406620A4 (en) | CYCLIC DERIVATIVE OF DICAFOYLSPERMIDINE AND USE THEREOF | |
| ZA202000959B (en) | Adamantylmethylamine derivative and use thereof as pharmaceutical | |
| EP3275879A4 (en) | Cyclic amine derivative and use thereof for medical purposes | |
| IL275991A (en) | A cyclic amine derivative and its medicinal use | |
| EP3275878A4 (en) | Cyclic amine derivative and use thereof for medical purposes | |
| GB201419354D0 (en) | Pharmaceutical extracts and uses thereof |